RinuaGene Biotechnology
PrivateCompany Overview
RinuaGene Biotechnology is a biotechnology company that develops innovative mRNA-based therapeutics and vaccines for oncology and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
mRNA therapeuticslipid nanoparticleLNPmRNA vaccinedrug discovery platformbiotech CDMOGMP productioncircular mRNAAI drug discoveryprotein replacement therapyRNA engineeringoncology therapeuticschemistry manufacturing and controlsCMCnext-gen mRNA
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RinuaGene Biotechnology Comparables
Compare RinuaGene Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RiboX Therapeutics | 85% | |
| Therorna Inc. | 84% | |
| Immorna Biotherapeutics | 84% | |
RinuaGene Biotechnology Funding Rounds
Historical fundraising activity
RinuaGene Biotechnology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about RinuaGene Biotechnology's valuation, stock price, and market status.
See something wrong or outdated?